Goodwin: Sound Bioventures Joins Fund Financing of Theolytics
April 24, 2024
April 24, 2024
BOSTON, Massachusetts, April 24 -- Goodwin, a law firm, issued the following news release:
The London Technology and Life Sciences team advised Sound Bioventures on its investment in the recent pound sterling19 million financing round of Theolytics. Sound Bioventures joins a strong existing investor syndicate comprising M Ventures, Taiho Ventures, Epidarex Capital, Oxford Science Enterprises and the University of Oxford.
Theolytics is developing oncolytic viral therapy . . .
The London Technology and Life Sciences team advised Sound Bioventures on its investment in the recent pound sterling19 million financing round of Theolytics. Sound Bioventures joins a strong existing investor syndicate comprising M Ventures, Taiho Ventures, Epidarex Capital, Oxford Science Enterprises and the University of Oxford.
Theolytics is developing oncolytic viral therapy . . .